Magna International Inc.
13.4.2026 23:00:00 CEST | Globenewswire | Press release
Magna International Inc. Announces Date for First Quarter 2026 Results Webcast
Magna International Inc. Announces Date for First Quarter 2026 Results Webcast
AURORA, Ontario, April 13, 2026 (GLOBE NEWSWIRE) -- Magna International Inc. (TSX:MG) (NYSE:MGA)
MAGNA INTERNATIONAL INC.
ANNOUNCES DATE FOR FIRST QUARTER 2026 RESULTS WEBCAST
FRIDAY, MAY 1, 2026 @ 8:00 AM ET
| LIVE AUDIO WEBCAST | ||
| Webcast registration: https://events.q4inc.com/attendee/900636883 | ||
| DIAL-IN DETAILS | ||
| Participant Toll-Free Dial-In: | 1-800-715-9871 | |
| Participant Toll Dial-In: | 1-646-307-1963 | |
| Conference ID: | 9829976 | |
| Slide presentation will be available on our website Investors | Magna prior to the call | ||
| REBROADCAST INFORMATION | ||
| Replay available 2 hours after the call until May 8, 2026 | ||
| Toll-Free Dial-In: | 1-800-770-2030 | |
| Toll Dial-In: | 1-609-800-9909 | |
| Conference ID: | 9829976 | |
INVESTOR CONTACT
Louis Tonelli, Vice-President, Investor Relations
louis.tonelli@magna.com 905-726-7035
WEBCAST CONTACT
Nancy Hansford, Executive Assistant, Investor Relations
nancy.hansford@magna.com 905-726-7108
ABOUT MAGNA INTERNATIONAL
Magna is one of the world’s largest automotive suppliers and a trusted partner to automakers in the industry’s most critical markets—North America, Europe, and China. With a global team and footprint spanning 28 countries, we bring unmatched scale, trusted reliability, and proven execution. Backed by nearly seven decades of experience, we combine deep manufacturing expertise with innovative vehicle systems to deliver performance, safety, and quality.
For further information about Magna (NYSE:MGA; TSX:MG), please visit www.magna.com or follow us on social.
Subscribe to releases from Globenewswire
Subscribe to all the latest releases from Globenewswire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Globenewswire
Zymeworks Inc.15.6.2026 00:05:00 CEST | Press release
Zymeworks Presents New Phase 1 Data for Folate Receptor Alpha-Targeting ADC ZW191 at ESMO Gynaecological Cancers Congress 2026
Crinetics Pharmaceuticals, Inc.14.6.2026 22:30:00 CEST | Press release
Crinetics Presents Full Results From Phase 2 Trial of Atumelnant in Congenital Adrenal Hyperplasia (CAH) in Oral Presentation at ENDO 2026
Crinetics Pharmaceuticals, Inc.14.6.2026 20:45:00 CEST | Press release
Crinetics Presents Long Term Data at ENDO 2026 Confirming PALSONIFY™ (paltusotine) Provides Durable, Consistent Acromegaly Control
King Faisal Specialist Hospital & Research Centre14.6.2026 09:01:00 CEST | Press release
KFSH Highlights Human-Centered AI as a Path to Better Care at HLTH Europe 2026
Genmab A/S13.6.2026 18:45:00 CEST | Press release
Genmab Announces Epcoritamab Monotherapy and Epcoritamab-Based Combination Regimens Demonstrate High Response Rates in Elderly Patients with Newly Diagnosed Diffuse Large B-Cell Lymphoma (DLBCL)
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom